Zacks Investment Management Bio Rad Laboratories, Inc. Transaction History

Zacks Investment Management

  • $11.4 Billion
  • Q3 2024

A detailed history of Zacks Investment Management transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Zacks Investment Management holds 1,620 shares of BIO stock, worth $547,122. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,620
Holding current value
$547,122
% of portfolio
0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$263.97 - $344.64 $427,631 - $558,316
1,620 New
1,620 $542,000
Q1 2024

May 15, 2024
BUY
$304.11 - $351.99 $4,561 - $5,279
15 Added 1.72%
887 $306,000
Q4 2023

Feb 14, 2024
SELL
$269.37 - $365.04 $7,003 - $9,491
-26 Reduced 2.9%
872 $281,000
Q3 2023

Nov 14, 2023
SELL
$350.25 - $422.63 $16,461 - $19,863
-47 Reduced 4.97%
898 $321,000
Q2 2023

Aug 15, 2023
BUY
$359.49 - $486.4 $7,189 - $9,728
20 Added 2.16%
945 $358,000
Q2 2023

Aug 14, 2023
SELL
$359.49 - $486.4 $3.97 Million - $5.37 Million
-11,039 Reduced 92.27%
925 $350,000
Q1 2023

May 15, 2023
BUY
$418.69 - $503.0 $2.4 Million - $2.88 Million
5,722 Added 91.67%
11,964 $5.73 Million
Q4 2022

Feb 14, 2023
SELL
$351.71 - $456.01 $79,838 - $103,514
-227 Reduced 3.51%
6,242 $2.63 Million
Q3 2022

Nov 14, 2022
BUY
$412.59 - $563.26 $2.34 Million - $3.2 Million
5,682 Added 721.98%
6,469 $2.7 Million
Q2 2022

Aug 15, 2022
SELL
$463.67 - $597.16 $1.77 Million - $2.28 Million
-3,825 Reduced 82.94%
787 $389,000
Q1 2022

May 13, 2022
BUY
$524.57 - $735.42 $2.03 Million - $2.85 Million
3,871 Added 522.4%
4,612 $2.6 Million
Q4 2021

Feb 15, 2022
BUY
$708.84 - $794.68 $708 - $794
1 Added 0.14%
741 $560,000
Q3 2021

Nov 15, 2021
SELL
$657.71 - $825.77 $657 - $825
-1 Reduced 0.13%
740 $552,000
Q2 2020

Aug 14, 2020
SELL
$334.87 - $493.06 $10,715 - $15,777
-32 Reduced 4.14%
741 $335,000
Q1 2020

May 15, 2020
BUY
$320.01 - $409.07 $7,680 - $9,817
24 Added 3.2%
773 $271,000
Q4 2019

Feb 14, 2020
BUY
$319.73 - $374.2 $319 - $374
1 Added 0.13%
749 $277,000
Q3 2019

Nov 14, 2019
SELL
$304.55 - $345.24 $1.06 Million - $1.2 Million
-3,489 Reduced 82.35%
748 $249,000
Q2 2019

Aug 14, 2019
BUY
$286.93 - $312.59 $1 Million - $1.09 Million
3,493 Added 469.49%
4,237 $1.33 Million
Q1 2019

May 15, 2019
BUY
$224.3 - $317.41 $166,879 - $236,153
744 New
744 $228,000
Q4 2018

Feb 14, 2019
SELL
$220.1 - $309.0 $163,754 - $229,896
-744 Closed
0 $0
Q3 2018

Nov 14, 2018
SELL
$289.28 - $326.15 $131,333 - $148,072
-454 Reduced 37.9%
744 $233,000
Q2 2018

Aug 14, 2018
BUY
$244.1 - $303.88 $292,431 - $364,048
1,198 New
1,198 $346,000

Others Institutions Holding BIO

# of Institutions
457
Shares Held
18.2M
Call Options Held
19.5K
Put Options Held
13.9K
View Full List

About BIO-RAD LABORATORIES, INC.

BIO Quotes by TradingView
  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.32B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Zacks Investment Management Portfolio

Follow Zacks Investment Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zacks Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Zacks Investment Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email